Abstract
Tumor acidosis affects every stage of cancer development, from dysplasia to full-blown metastatic disease. Survival strategies of malignant cells in an acidic microenvironment and pH gradient inversion promote resistance to chemotherapy, radiotherapy and immunotherapy, and suppress the antitumor immune response. It is necessary to consider the low pH of the microenvironment both when diagnosing and when choosing the most optimal treatment regimen. The development of methods for non-invasive measurement of tumor pH, methods for direct and indirect correction of acidosis, new pH-activated and pH-targeted drugs is required. In this work, we consider some aspects related to the altered acid-base state of the tumor, which may be significant for the clinician.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.